Medscape6d
The Glucagonostatic and Insulinotropic Effects of Glucagon-like Peptide 1 Contribute Equally to its Glucose-lowering Action
Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...
Healthline1d
Can You Drink Alcohol With Ozempic?
Find out if it's safe to drink alcohol during your Ozempic treatment, whether alcohol raises the risk of any sides effects, ...
Scientists Explain ‘Ozempic Blindness,’ Link Between Sudden Vision Loss and Weight Loss Drugs
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
TCTMD3d
Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity
The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...
All-you-can’t-eat: GLP-1 drugs pose new challenges for restaurants, but how do they work?
When Trova Wine and Market shut its doors last month after nearly five years in business in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like ...
pharmaphorum3d
Lilly’s Mounjaro wins latest head-to-head battle in clinical trials of diabetes treatments
Their health may improve throughout the trial, simply due to the effects of other drugs they are taking. Other factors are also at play, such as a multitude of studies or a varied patient population.
Medscape3d
DPP-4 Inhibitors -- An Update on Alogliptin
Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...